EU-Japan Biotech & Pharma Partnering Conference 2026

16 Sept – 5 Oct 2026 | Osaka, Japan

HomeAgenda
Register
Register
Register

ServiceUpdated on 9 September 2026

Preclinical services in Cardiology Cardiovascular and cardiometabolic diseases

About

  •  Your partner in cardiovascular health innovation, to accelerate and secure your pipeline in the evaluation of drug candidates and medical devices.

Over 25 years of experience serving an international clientele.

Our offer: a range of animal models for cardiovascular, cardiometabolic, cardiopulmonary, and thrombotic diseases, as well as several in vitro coagulation and fibrinolysis tests on human blood.

A state-of-the-art environment to ensure robust, high-quality, and repeatable results: bioanalytical services (ELISA, WB, multiplexed assays, IHC) and high‑performance imaging (MRI, PET-Scan, MPI, echocardiography, fUS, HCS).

Type

  • Development
  • Consulting
  • Others

Applies to

  • Biotech and Lifescience
  • Medtech

Organisation

SYNCROSOME (ETAP SA)

Company (SME/startup) / 中小企業・スタートアップ

MARSEILLE, France

Similar opportunities